Eric K. Nicholson

Array ( [id] => 326437 [patent_doc_number] => 07514208 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-07 [patent_title] => 'Methods for identifying modulators of cyclic nucleotide-gated cation channels' [patent_app_type] => utility [patent_app_number] => 11/736156 [patent_app_country] => US [patent_app_date] => 2007-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 24321 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/514/07514208.pdf [firstpage_image] =>[orig_patent_app_number] => 11736156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6627687 [patent_doc_number] => 20100004166 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'Endothelin and Endothelin Receptor Agonists in the Treatment of Metabolic Diseases' [patent_app_type] => utility [patent_app_number] => 12/294235 [patent_app_country] => US [patent_app_date] => 2007-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10024 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20100004166.pdf [firstpage_image] =>[orig_patent_app_number] => 12294235 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6222410 [patent_doc_number] => 20100056441 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'Method for Inhibiting Angiogenesis' [patent_app_type] => utility [patent_app_number] => 12/282113 [patent_app_country] => US [patent_app_date] => 2007-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 17655 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20100056441.pdf [firstpage_image] =>[orig_patent_app_number] => 12282113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5385684 [patent_doc_number] => 20090226929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'TITINIC ION CHANNEL, COMPOSITIONS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/225051 [patent_app_country] => US [patent_app_date] => 2007-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 21659 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20090226929.pdf [firstpage_image] =>[orig_patent_app_number] => 12225051 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8845776 [patent_doc_number] => 08454952 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-04 [patent_title] => 'Augmentation of endothelial thromboresistance' [patent_app_type] => utility [patent_app_number] => 12/282769 [patent_app_country] => US [patent_app_date] => 2007-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 33 [patent_no_of_words] => 12291 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12282769 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5220256 [patent_doc_number] => 20070161567 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-12 [patent_title] => 'Method of reducing the risk of bone fracture' [patent_app_type] => utility [patent_app_number] => 11/684996 [patent_app_country] => US [patent_app_date] => 2007-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 18057 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20070161567.pdf [firstpage_image] =>[orig_patent_app_number] => 11684996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 177687 [patent_doc_number] => 07655395 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-02 [patent_title] => 'Isolation and use of ryanodine receptors' [patent_app_type] => utility [patent_app_number] => 11/715725 [patent_app_country] => US [patent_app_date] => 2007-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 21849 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/655/07655395.pdf [firstpage_image] =>[orig_patent_app_number] => 11715725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8994529 [patent_doc_number] => 08518411 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-27 [patent_title] => 'Modified TGF-β superfamily protein' [patent_app_type] => utility [patent_app_number] => 11/715679 [patent_app_country] => US [patent_app_date] => 2007-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 32 [patent_no_of_words] => 33555 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11715679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5119930 [patent_doc_number] => 20070141644 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Novel Receptors' [patent_app_type] => utility [patent_app_number] => 11/680133 [patent_app_country] => US [patent_app_date] => 2007-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 24278 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20070141644.pdf [firstpage_image] =>[orig_patent_app_number] => 11680133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 348537 [patent_doc_number] => 07494650 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-24 [patent_title] => 'Monoclonal antibodies to hepatocyte growth factor' [patent_app_type] => utility [patent_app_number] => 11/710009 [patent_app_country] => US [patent_app_date] => 2007-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10830 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/494/07494650.pdf [firstpage_image] =>[orig_patent_app_number] => 11710009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5398281 [patent_doc_number] => 20090318344 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'COMPOSITIONS AND METHODS FOR MODULATING HEMOSTASIS USING VARIANT FORMS OF ACTIVATED FACTOR V' [patent_app_type] => utility [patent_app_number] => 12/162935 [patent_app_country] => US [patent_app_date] => 2007-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12625 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20090318344.pdf [firstpage_image] =>[orig_patent_app_number] => 12162935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4965743 [patent_doc_number] => 20080108563 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'Novel polypeptides having sequence similarity to GDNFR and nucleic acids encoding the same' [patent_app_type] => utility [patent_app_number] => 11/708911 [patent_app_country] => US [patent_app_date] => 2007-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 32823 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20080108563.pdf [firstpage_image] =>[orig_patent_app_number] => 11708911 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4988136 [patent_doc_number] => 20070154475 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-05 [patent_title] => 'Novel polypeptides having sequence similarity to GDNFR and nucleic acids encoding the same' [patent_app_type] => utility [patent_app_number] => 11/709185 [patent_app_country] => US [patent_app_date] => 2007-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 32807 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20070154475.pdf [firstpage_image] =>[orig_patent_app_number] => 11709185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5538710 [patent_doc_number] => 20090220515 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'TREATMENT AND PREVENTION OF RENAL DISEASE' [patent_app_type] => utility [patent_app_number] => 12/279128 [patent_app_country] => US [patent_app_date] => 2007-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14123 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20090220515.pdf [firstpage_image] =>[orig_patent_app_number] => 12279128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4927443 [patent_doc_number] => 20080166806 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-10 [patent_title] => 'Attenuated Effector Ligand' [patent_app_type] => utility [patent_app_number] => 11/621103 [patent_app_country] => US [patent_app_date] => 2007-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6369 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20080166806.pdf [firstpage_image] =>[orig_patent_app_number] => 11621103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4670636 [patent_doc_number] => 20080045696 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'DNA Molecules Encoding L-Glutamate-Gated Chloride Channels From Rhipicephalus Sanguineus' [patent_app_type] => utility [patent_app_number] => 11/620347 [patent_app_country] => US [patent_app_date] => 2007-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 20148 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20080045696.pdf [firstpage_image] =>[orig_patent_app_number] => 11620347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4506206 [patent_doc_number] => 07915010 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2011-03-29 [patent_title] => 'DNA molecules encoding L-glutamate-gated chloride channels from Rhipicephalus sanguineus' [patent_app_type] => utility [patent_app_number] => 11/620435 [patent_app_country] => US [patent_app_date] => 2007-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 20264 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/915/07915010.pdf [firstpage_image] =>[orig_patent_app_number] => 11620435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5489989 [patent_doc_number] => 20090291060 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-26 [patent_title] => 'Treatment of HIV' [patent_app_type] => utility [patent_app_number] => 12/087442 [patent_app_country] => US [patent_app_date] => 2007-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4615 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20090291060.pdf [firstpage_image] =>[orig_patent_app_number] => 12087442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4778772 [patent_doc_number] => 20080286770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-20 [patent_title] => 'DNA Molecules Encoding L-Glutamate-Gated Chloride Channels From Rhipicephalus Sanguineus' [patent_app_type] => utility [patent_app_number] => 11/620390 [patent_app_country] => US [patent_app_date] => 2007-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 20136 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20080286770.pdf [firstpage_image] =>[orig_patent_app_number] => 11620390 [rel_patent_id] =>[rel_patent_doc_number] =>)